LEARN MORE ABOUT
Understanding KYMRIAH
KYMRIAH® (tisagenlecleucel) is a type of immunotherapy for patients with relapsed or refractory (r/r) B-cell ALL. Discover how KYMRIAH works, what makes it different from other therapies, and whether it could be right for you.
LEARN MORE ABOUT
Where to Get Treatment
KYMRIAH is available at select treatment centers across the United States. Click below to find the locations nearest to you.
Downloadable Resources
Download helpful materials to support you throughout KYMRIAH therapy.
KYMRIAH CARES
Learn about KYMRIAH CARES™, a program that has resources to help you throughout your treatment journey.
Speak With A Real Patient
The Leukemia & Lymphoma Society (LLS) provides The Patti Robinson Kaufmann First Connection Program, which offers peer-to-peer support from patients, family members, caregivers, or peer volunteers who have gone through a similar experience